Biodesix, Inc.
BDSX
$0.50
-$0.049-8.93%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 9.72% | 6.31% | 19.08% | 27.21% | 55.06% |
| Total Depreciation and Amortization | 11.03% | 20.42% | -0.42% | -8.09% | -20.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.37% | -52.40% | -3.55% | -0.37% | -63.06% |
| Change in Net Operating Assets | 109.77% | -269.39% | -214.71% | -222.71% | -1,304.65% |
| Cash from Operations | 66.65% | -178.04% | -2,081.96% | -99.21% | -2.80% |
| Capital Expenditure | 71.88% | 96.05% | 69.99% | 96.95% | -54.61% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -164.71% | -34.15% | -29.09% | -30.00% | 70.18% |
| Cash from Investing | 70.54% | 95.14% | 69.14% | 96.46% | -51.03% |
| Total Debt Issued | -- | -- | -- | -- | -66.67% |
| Total Debt Repaid | 0.00% | -8.33% | 0.00% | -8.33% | 99.94% |
| Issuance of Common Stock | -99.95% | -97.72% | 67,806.17% | 113.62% | -69.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 83.64% | 94.17% | -54.06% | 96.26% | 82.96% |
| Cash from Financing | -100.83% | -98.82% | 2,301.55% | 132.67% | -48.08% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -180.09% | -544.80% | 490.69% | 16.95% | -76.91% |